Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

130 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Clinical Trials for COVID-19: Can we Better Use the Short Window of Opportunity?
Eichler HG, Cavaleri M, Enzmann H, Scotti F, Sepodes B, Sweeney F, Vamvakas S, Rasi G. Eichler HG, et al. Among authors: enzmann h. Clin Pharmacol Ther. 2020 Oct;108(4):730-733. doi: 10.1002/cpt.1891. Epub 2020 Jun 12. Clin Pharmacol Ther. 2020. PMID: 32407539 Free PMC article. Review.
Attention for sex in COVID-19 trials: a review of regulatory dossiers.
de Vries ST, Starokozhko V, Schellens IMM, Wijnans L, Enzmann H, Cavaleri M, Mol PGM. de Vries ST, et al. Among authors: enzmann h. BMJ Glob Health. 2022 Mar;7(3):e008173. doi: 10.1136/bmjgh-2021-008173. BMJ Glob Health. 2022. PMID: 35304352 Free PMC article. Review.
Added therapeutic benefit and drug licensing.
Eichler HG, Enzmann H, Rasi G. Eichler HG, et al. Among authors: enzmann h. Nat Rev Drug Discov. 2019 Sep;18(9):651-652. doi: 10.1038/d41573-019-00068-x. Nat Rev Drug Discov. 2019. PMID: 31477854 No abstract available.
EMA Review of Belantamab Mafodotin (Blenrep) for the Treatment of Adult Patients with Relapsed/Refractory Multiple Myeloma.
Tzogani K, Penttilä K, Lähteenvuo J, Lapveteläinen T, Lopez Anglada L, Prieto C, Garcia-Ochoa B, Enzmann H, Gisselbrecht C, Delgado J, Pignatti F. Tzogani K, et al. Among authors: enzmann h. Oncologist. 2021 Jan;26(1):70-76. doi: 10.1002/onco.13592. Epub 2020 Nov 23. Oncologist. 2021. PMID: 33179377 Free PMC article. Clinical Trial.
The European Medicines Agency review of entrectinib for the treatment of adult or paediatric patients with solid tumours who have a neurotrophic tyrosine receptor kinase gene fusions and adult patients with non-small-cell lung cancer harbouring ROS1 rearrangements.
Delgado J, Pean E, Melchiorri D, Migali C, Josephson F, Enzmann H, Pignatti F. Delgado J, et al. Among authors: enzmann h. ESMO Open. 2021 Apr;6(2):100087. doi: 10.1016/j.esmoop.2021.100087. Epub 2021 Mar 16. ESMO Open. 2021. PMID: 33735800 Free PMC article. Review.
130 results